Current treatment modalities for dry eye disease

<p> <br> </p> <p> <b>E.B.&nbsp;Tatarnikova, O.I.&nbsp;Krivosheina</b> </p> <p> <b>Siberian State Medical University, Tomsk, Russian Federation</b> </p> <p> <i>For many years, dry eye disease (DED) is a common o...

Full description

Bibliographic Details
Main Authors: E.B. Tatarnikova, O.I. Krivosheina
Format: Article
Language:Russian
Published: Prime-Media 2021-03-01
Series:РМЖ "Клиническая офтальмология"
Online Access:http://clinopht.com/upload/iblock/d2a/d2a5a17a98fe2a1dd8646d3b979a3b3a.pdf
id doaj-797c55c6c5e5418a83bea6db4b0697c0
record_format Article
spelling doaj-797c55c6c5e5418a83bea6db4b0697c02021-09-16T13:40:14ZrusPrime-Media РМЖ "Клиническая офтальмология"2311-77292619-15712021-03-0121131269Current treatment modalities for dry eye diseaseE.B. Tatarnikova0O.I. Krivosheina1Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399<p> <br> </p> <p> <b>E.B.&nbsp;Tatarnikova, O.I.&nbsp;Krivosheina</b> </p> <p> <b>Siberian State Medical University, Tomsk, Russian Federation</b> </p> <p> <i>For many years, dry eye disease (DED) is a common ophthalmic condition associated with ocular surface damage and loss of homeostasis of the tear film. The key pathogenic factors of DED are tear film instability and tear hyperosmolarity, ocular surface inflammation and damage, and neurosensory alterations. Current treatment for DED consists of non-medical therapies, tear substitutes, anti-inflammatory agents, and surgical procedures. These treatments improve disease course and quality of life. However, these treatments are largely palliative as long-term (and even life-long) installation of eye drops is required. Modern and effective treatments for DED are needed. This paper reviews domestic and foreign published data on the important therapies for DED and novel tools to promote symptom relief. These data are required for the understanding of the pharmacological effects of various drug classes prescribed for DED and early treatment initiation.</i> </p> <p> <i><b>Keywords</b>: dry eye disease, tear replacement therapy, anti-inflammatory treatment, surgery, hyaluronic acid, preservatives.</i> </p> <p> <i><b>For citation: </b>Tatarnikova E.B., Krivosheina O.I. Current treatment modalities for dry eye disease. Russian Journal of Clinical Ophthalmology. 2021;21(1):18–23. DOI: 10.32364/2311-7729-2021-21-1-18-23.</i> </p>http://clinopht.com/upload/iblock/d2a/d2a5a17a98fe2a1dd8646d3b979a3b3a.pdf
collection DOAJ
language Russian
format Article
sources DOAJ
author E.B. Tatarnikova
O.I. Krivosheina
spellingShingle E.B. Tatarnikova
O.I. Krivosheina
Current treatment modalities for dry eye disease
РМЖ "Клиническая офтальмология"
author_facet E.B. Tatarnikova
O.I. Krivosheina
author_sort E.B. Tatarnikova
title Current treatment modalities for dry eye disease
title_short Current treatment modalities for dry eye disease
title_full Current treatment modalities for dry eye disease
title_fullStr Current treatment modalities for dry eye disease
title_full_unstemmed Current treatment modalities for dry eye disease
title_sort current treatment modalities for dry eye disease
publisher Prime-Media
series РМЖ "Клиническая офтальмология"
issn 2311-7729
2619-1571
publishDate 2021-03-01
description <p> <br> </p> <p> <b>E.B.&nbsp;Tatarnikova, O.I.&nbsp;Krivosheina</b> </p> <p> <b>Siberian State Medical University, Tomsk, Russian Federation</b> </p> <p> <i>For many years, dry eye disease (DED) is a common ophthalmic condition associated with ocular surface damage and loss of homeostasis of the tear film. The key pathogenic factors of DED are tear film instability and tear hyperosmolarity, ocular surface inflammation and damage, and neurosensory alterations. Current treatment for DED consists of non-medical therapies, tear substitutes, anti-inflammatory agents, and surgical procedures. These treatments improve disease course and quality of life. However, these treatments are largely palliative as long-term (and even life-long) installation of eye drops is required. Modern and effective treatments for DED are needed. This paper reviews domestic and foreign published data on the important therapies for DED and novel tools to promote symptom relief. These data are required for the understanding of the pharmacological effects of various drug classes prescribed for DED and early treatment initiation.</i> </p> <p> <i><b>Keywords</b>: dry eye disease, tear replacement therapy, anti-inflammatory treatment, surgery, hyaluronic acid, preservatives.</i> </p> <p> <i><b>For citation: </b>Tatarnikova E.B., Krivosheina O.I. Current treatment modalities for dry eye disease. Russian Journal of Clinical Ophthalmology. 2021;21(1):18–23. DOI: 10.32364/2311-7729-2021-21-1-18-23.</i> </p>
url http://clinopht.com/upload/iblock/d2a/d2a5a17a98fe2a1dd8646d3b979a3b3a.pdf
work_keys_str_mv AT ebtatarnikova currenttreatmentmodalitiesfordryeyedisease
AT oikrivosheina currenttreatmentmodalitiesfordryeyedisease
_version_ 1717378236058435585